✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹2,116 Cr.
P/E
0.00
About
Astec Lifesciences Limited, founded in 1994, specializes in manufacturing agrochemicals and pharmaceutical intermediates. With over 25 years of experience, the company has established strong global pa… Read more
Astec Lifesciences Limited, founded in 1994, specializes in manufacturing agrochemicals and ph… Read more
Low
825
52W Range
High
1474
  • Astec Lifesciences
  • India Pesticides
  • Insecticides India

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

5 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Suppliers
    • HLE Glascoat Ltd.
    FAQs on Astec Lifesciences Ltd. Business

    Astec Lifesciences Limited, established in 1994, is a global leader in manufacturing agrochemicals and pharmaceutical intermediates. The company exports to over 25 countries and holds certifications like Responsible Care from ICCA.

    Astec Lifesciences major competitors are India Pesticides, Insecticides India, Meghmani Organics, Heranba Industries, Excel Industries, Best Agrolife, The Yamuna Syndicate.
    Market Cap of Astec Lifesciences is ₹2,116 Crs.
    While the median market cap of its peers are ₹1,691 Crs.

    Astec Lifesciences seems to be less financially stable compared to its competitors.
    Altman Z score of Astec Lifesciences is 2.91 and is ranked 6 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Dec Sep Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Dec Sep Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Dec Sep Jun Mar Mar Jun Sep Dec Jun Dec Mar Jun Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis